Tilbage til tagliste | 21261 | dndn news | 2/11 2009 13:57 | Hya | 4  |
| Dendreon Completes Submission of Biologics License Application for PROVENGE SEATTLE (November 2, 2009) - Dendreon Corporation (Nasdaq: DNDN) today announced that it has completed the submission of the amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T), the Company's lead inve | ||||
|
|
|